World Wires · story 120439 · official · 1 source(s)

SCHEDULE 13D/A: Redmile Group, LLC discloses a stake in Fate Therapeutics Inc

Filed: 2026-11-09 AccNo: 0000905148-26-004718 Size: 31 KB

Open in the desk

Coverage

• SCHEDULE 13D/A: Redmile Group, LLC discloses a stake in Fate Therapeutics Inc SEC EDGAR: Schedule 13D stakes · tier A · clear net · 2026-11-10 00:08 UTC

What this site indexes